Premium cigars in the US: premium is not enough

In the United States, “premium” lives not only on a label or in a brand’s reputation. In 2026 it has become the meeting point of the FDA, courts, importers and California authorities. The same reference can be described as premium and, at the same time, face different rules for user fees, importation or sale.

In the US, premium is an eight-part test

In its 15 April 2026 document, FDA requires all eight criteria at once. They include a whole-leaf wrapper and all-tobacco binder; at least 50% long filler; hand-rolling; no filter or characterising flavours other than tobacco; only tobacco, water and vegetable gum; and a weight above six pounds per 1,000 cigars.

A brand calling a cigar premium is therefore not enough, nor is a sale in an upscale lounge. If one technical requirement is missing, the classification may change for that regulatory process.

User fees are moving through a transition

FDA has stated that it intends not to assess its user fees on premium cigars following court decisions. The automatic mechanism is not ready, however: invoices may temporarily include all cigars and manufacturers or importers must dispute the premium share with documentation within 45 days. How the unallocated share will be redistributed remains unresolved.

The transition also has an economic weight: until the mechanism becomes automatic, the definition will remain tied to the technical documents submitted by manufacturers or importers. It is not a medal to attach once and forget, but a condition to demonstrate in the relevant process.

A factory is not the same thing as the product it makes

The proposal published in the Federal Register on 29 June 2026 would extend registration, product listing and inspections to foreign establishments exporting tobacco to the US. Its footnote refers to the exception for premium cigars not subject to Chapter IX, but the perimeter remains linked to litigation over the definition.

A factory may produce both cigars within the exception and references subject to FDA requirements. The distinction matters across the supply chain: the factory’s name alone does not describe the regulatory position of every reference.

In California, the decisive word is saleable

California keeps its Unflavored Tobacco List: a premium cigar must be on the list before it can be sold in the state. The Ninth Circuit decision of 27 August 2026 left the regime in place while litigation continues. Natural sensory descriptions — leather, cocoa, fruit or spice — are not automatically added flavours, but the required certification remains decisive.

It is a small difference in wording and a large difference in information quality: in the United States, availability is not an absolute characteristic of a cigar, but a relationship with the market in which it is offered.

When a word becomes a rule

The American story shows how fragile the line can be between editorial language and regulatory language. “Premium” can describe a production culture, a position or an experience; for the FDA, it is a definition measured against technical requirements. In California, the same word still cannot tell us on its own whether a product may be sold.

For readers, the consequence is simple but easy to miss: a cigar’s availability must be read in its market, not only next to the brand name. For those who make or import it, product, establishment and jurisdiction must remain separate. Bureaucracy is no longer a side note; it is part of the premium cigar’s commercial story.

Premium is not a passport: it is a definition that must survive the test of the market.

Why this story matters

The word premium will remain part of the sector’s language, but in the United States it can no longer stand alone. The question is becoming more concrete: premium under which rule, in which establishment and for which market? Until the answer is documented, every commercial certainty remains incomplete.